Catalysts for Riconpharma LLC
15 tracked
Mar 9, 2026
approval
OXCARBAZEPINE — FDA approval
Riconpharma LLC
→
Feb 9, 2026
approval
SCOPOLAMINE — FDA approval
scopolamine ER
→
Feb 9, 2026
approval
SCOPOLAMINE — FDA approval
scopolamine ER
→
Feb 9, 2026
approval
SCOPOLAMINE — FDA approval
scopolamine ER
→
Feb 9, 2026
approval
SCOPOLAMINE — FDA approval
Riconpharma LLC
→
Feb 9, 2026
approval
SCOPOLAMINE — FDA approval
Riconpharma LLC
→
Jan 27, 2026
approval
MESNA — FDA approval
Riconpharma LLC
→
Sep 30, 2025
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
Riconpharma LLC
→
Sep 26, 2025
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
Riconpharma LLC
→
Oct 27, 2023
approval
SCOPOLAMINE — FDA approval
Riconpharma LLC
→
Jun 10, 2022
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
Riconpharma LLC
→
Nov 24, 2020
approval
SCOPOLAMINE — FDA approval
scopolamine ER
→
Mar 27, 2019
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
Riconpharma LLC
→
Jan 25, 2019
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
Riconpharma LLC
→
Jan 30, 2015
approval
SCOPOLAMINE — FDA approval
Riconpharma LLC
→